| Number of patients | 168 |
| Age, yrs | 29 (2-71) |
| Type of hemophilia | |
| A | 143 (85%) |
| B | 25 (15%) |
| Severity of hemophilia | |
| Severe | 112 (67%) |
| Moderate | 16 (9%) |
| Mild | 40 (24%) |
| Type of concentrates | |
| Nonvirus-inactivated (until 1985) | 128 (75%) |
| Virus-inactivated only | 33 (20%) |
| Recombinant | 7 (4%) |
| Number of patients | 168 |
| Age, yrs | 29 (2-71) |
| Type of hemophilia | |
| A | 143 (85%) |
| B | 25 (15%) |
| Severity of hemophilia | |
| Severe | 112 (67%) |
| Moderate | 16 (9%) |
| Mild | 40 (24%) |
| Type of concentrates | |
| Nonvirus-inactivated (until 1985) | 128 (75%) |
| Virus-inactivated only | 33 (20%) |
| Recombinant | 7 (4%) |